Company: ISRG
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001035267-25-000098
Chunk: 26

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 26
---
 objectives, and policies and practices that contributed to our executive compensation actions and decisions for our 2024 named executive officers (our “NEOs”), who are listed below.

| Name                   |     | Position During 2024                                                           |
| Gary S. Guthart, Ph.D. |     | Chief Executive Officer                                                        |
| Jamie E. Samath(1)     |     | Senior Vice President, Chief Financial Officer and Head of Business Technology |
| David J. Rosa          |     | President                                                                      |
| Henry L. Charlton(2)   |     | Senior Vice President and Chief Commercial and Marketing Officer               |
| Brian E. Miller, Ph.D. |     | Executive Vice President and Chief Digital Officer                             |

(1) Mr. Samath served as our Senior Vice President, Chief Financial Officer during 2024 prior to taking on an expanded role, effective July 1, 2024, when Mr. Samath transitioned to the position of Senior Vice President, Chief Financial Officer and Head of Business Technology. Effective January 1, 2025, Mr. Samath was promoted to Executive Vice President, Chief Financial Officer and Head of Business Technology.

(2) Effective January 1, 2025, Mr. Charlton was promoted to Executive Vice President, Chief Commercial and Marketing Officer of the Company.

#### Executive Summary
The primary objective of our executive compensation program is to attract and retain a passionate team of executives who drive innovation that enables physicians and healthcare providers to improve the quality of and access to minimally invasive care. We seek to accomplish this goal in a way that is aligned with the long-term interests of our stockholders. Our strategy has been to provide a level of fairness within our programs to drive alignment of all employees, including our NEOs. This approach recognizes that, as a company, we are all one team with one mission. We believe our executive compensation program effectively aligns the interests of our NEOs with our objective of creating sustainable long-term value for our stockholders.

### 2024 Financial Highlights
During 2024, we continued to grow the number of procedures performed worldwide using our products. In the U.S., the procedure growth was largely attributable to strong growth in general surgery procedures, most notably cholecystectomy, hernia repair, and colorectal procedures. OUS procedure growth was driven by growth in general surgery procedures, most notably colorectal and hernia repair procedures, urologic procedures, most notably prostatectomy and partial nephrectomy procedures, and g